N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease

Clinical trial NCT05589766 · COMPLETED

Trial details

NCT number: NCT05589766
Sponsor: Haukeland University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2023-01-23
Primary completion: 2025-04-22
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.